Tower Research Capital LLC (TRC)
Position in RLAY — Relay Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in RLAY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$361,608
+$254,954 QoQ
Shares Held
19,327
+80.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#168
of 258 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. RLAY ranks #25 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $361,608 | 19,327 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $106,654 | 10,719 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,761 | 681 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $44,897 | 8,601 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $40,014 | 11,565 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $31,358 | 11,969 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $111,767 | 27,128 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $149,034 | 21,050 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $145,004 | 22,240 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,411 | 411 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $191,573 | 17,400 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $19,039 | 2,264 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $130,145 | 10,362 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,292 | 4,490 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $155,464 | 10,406 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $204,931 | 9,161 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $254,281 | 15,181 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $81,050 | 2,708 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $233,671 | 7,609 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $275,571 | 8,740 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $133,077 | 3,637 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $126,422 | 3,657 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $294,410 | 7,084 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $218,230 | 5,124 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||